Home › Funds › Alta Fundamental Advisers LLC › INDV
Alta Fundamental Advisers LLC position in INDV
INDIVIOR PHARMACEUTICALS INC · Health Care
Alta Fundamental Advisers LLC reported holding 404,529 shares of INDV (INDIVIOR PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$14.5M, representing 6.44% of its reported portfolio and ranking #5 among its reported holdings. Alta Fundamental Advisers LLC has disclosed INDV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Alta Fundamental Advisers LLC's INDV position evolved
Alta Fundamental Advisers LLC first disclosed a stake in INDV in Q3 2023 at 150,000 shares (US$2.7M). The position peaked in Q2 2026 at 404,529 shares, worth US$16.6M. Across 13 filings, Alta Fundamental Advisers LLC increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 404,529 shares valued at US$14.5M. Notable position changes include a 117% increase in Q2 2024 (shares fell 23% over the following quarter), a 72% increase in Q2 2025 (shares rose 64% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 150.00K | $2.67M | New |
| Q4 2023 | 150.00K | $1.78M | Hold |
| Q1 2024 | 150.00K | $2.54M | Hold |
| Q2 2024 | 325.00K | $4.03M | Add |
| Q3 2024 | 325.00K | $2.39M | Hold |
| Q4 2024 | 400.00K | $4.97M | Add |
| Q1 2025 | 334.47K | $3.19M | Reduce |
| Q2 2025 | 575.05K | $8.48M | Add |
| Q3 2025 | 475.05K | $11.45M | Reduce |
| Q4 2025 | 409.53K | $14.69M | Reduce |
| Q1 2026 | 409.53K | $12.48M | Hold |
| Q2 2026 | 404.53K | $16.60M | Reduce |
| Q3 2026 | 404.53K | $14.50M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About INDV and 13F data
INDV (INDIVIOR PHARMACEUTICALS INC) is a Health Care company. 51 other funds we track also report a position in INDV — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), Two Seas Capital LP (US$131.6M), Madison Avenue Partners, LP (US$117.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INDV
- OAKTREE CAPITAL MANAGEMENT LP 6.13M sh · $251.40M · Q2 2026
- Two Seas Capital LP 3.67M sh · $131.61M · Q3 2026
- Madison Avenue Partners, LP 2.87M sh · $117.94M · Q2 2026
- MANGROVE PARTNERS IM, LLC 2.68M sh · $109.83M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.65M sh · $67.65M · Q2 2026
- Jones Hill Capital LP 1.53M sh · $54.73M · Q3 2026
- Newtyn Management, LLC 1.31M sh · $53.58M · Q2 2026
- GENDELL JEFFREY L 1.10M sh · $44.98M · Q2 2026
- Soleus Capital Management, L.P. 1.06M sh · $43.66M · Q2 2026
- Claret Asset Management Corp 685.52K sh · $28.13M · Q2 2026
- Westchester Capital Management, LLC 775.86K sh · $27.81M · Q3 2026
- Divisadero Street Capital Management, LP 601.86K sh · $24.69M · Q2 2026
More on Alta Fundamental Advisers LLC
FAQ
How long has Alta Fundamental Advisers LLC held INDV?
Alta Fundamental Advisers LLC has disclosed INDV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Alta Fundamental Advisers LLC's current position in INDV?
As of Q3 2026, Alta Fundamental Advisers LLC holds 404.53K shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $14.50M, representing 6.44% of its reported portfolio and ranking #5.
Has Alta Fundamental Advisers LLC been buying or selling INDV?
In the latest 13F filing (Q3 2026), Alta Fundamental Advisers LLC held unchanged its position in INDV. The position peaked in Q2 2026 at 404.53K shares.
Which other funds hold INDV?
Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, Two Seas Capital LP, Madison Avenue Partners, LP, among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.